Status:
ACTIVE_NOT_RECRUITING
Financial Distress in Advanced Cancer Patients
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Advanced Malignant Neoplasm
Locally Advanced Malignant Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This trial studies the severity of financial distress in advanced cancer patients. The cost of cancer care can often be very expensive. Financial distress from the burdens of high costs and debt may i...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the frequency of high financial distress in advanced cancer patients. SECONDARY OBJECTIVES: I. To determine the association between high financial distress with ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient must have a diagnosis of advanced cancer, as defined by recurrent disease, locally advanced disease, metastatic disease, or refractory disease
- Patients must be able to understand, read, write, and speak English
- Patients must have no clinical evidence of severe cognitive impairment (Memorial Delirium Assessment Scale score of \>= 13) and should be able to consent and answer the questionnaires
- Patients must sign an informed consent
Exclusion
Key Trial Info
Start Date :
July 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2027
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT04053517
Start Date
July 2 2019
End Date
December 31 2027
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030